Descrição

Bioavailability and absorption kinetics of EPA versus DHA from different supplement forms including triglycerides, ethyl esters, and phospholipids are compared.

Figure 15

Chart

Source Paper

Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other?

Nutrients (2020)

PMID: 33276463

DOI: 10.3390/nu12123718

Cite This Figure

![Figure 15: Bioavailability and absorption kinetics of EPA versus DHA from different supplement forms including triglycerides, ethyl esters, and phospholipids are compared.]()

> Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." *Nutrients*, 2020. PMID: [33276463](https://pubmed.ncbi.nlm.nih.gov/33276463/)

<figure>
  <img src="" alt="Bioavailability and absorption kinetics of EPA versus DHA from different supplement forms including triglycerides, ethyl esters, and phospholipids are compared." />
  <figcaption>Figure 15. Bioavailability and absorption kinetics of EPA versus DHA from different supplement forms including triglycerides, ethyl esters, and phospholipids are compared.<br>  Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33276463/">33276463</a></figcaption>
</figure>

Evidências Relacionadas

Omega-3 Fatty Acids (EPA/DHA) para Chronic Inflammation

Nota A · 30 estudos